Mitch McKenny is unlikely to run again after spending four weeks running from Broken Hill to Newcastle, including the last ...

MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Children's Health Foundation of Vancouver Island's Bear Essentials program shares vital support for Island kids ...

Angelman syndrome is a rare genetic, nondegenerative and neurodevelopmental disorder caused by mutations affecting the ...

An East Renfrewshire business that sells specialist beds for children with disabilities has doubled turnover and moved into new premises after receiving scale-up support from Business Gateway.

JP Morgan upgrades Ionis Pharmaceuticals to overweight, citing Tryngolza expansion and strong pipeline. Read more here.

Advancing rare disease care with innovation, trials, and specialised clinics ...

Supporters of the Boys & Girls Club of the Lakes Region gathered at The Margate on Tuesday morning to hear from parents, ...

Ultragenyx (RARE) stock is down 40% since March 2024 amid ongoing financial struggles. See more insights on its growth ...

A business that helps families of disabled children travel more easily has doubled its turnover and moved into new premises.